The right scale of fuel : Stamford-based Sema4 eyes more growth by going public
FacebookTwitterEmail
State Rep. Matt Blumenthal, at left, and Sen. Chris Murphy, at center, tour Sema4 s laboratory at 62 Southfield Ave., in Stamford, Conn., on Sept. 18, 2020.Matthew Brown / Hearst Connecticut Media
STAMFORD Health care information provider Sema4 announced Wednesday that it would become a publicly traded company, an ambitious plan intended to catalyze further growth for one of the fastest-expanding firms in Connecticut.
In a move that values the company at approximately $2 billion, Stamford-headquartered Sema4 is going public through a process that offers an alternative to an initial public offering. It would result in Sema4’s shares trading on the Nasdaq Global Market upon the transaction’s expected completion in the second quarter of this year.
A significant milestone : Stamford health care information firm Sema4 to become public company
FacebookTwitterEmail
1of6
Emmett Higgins, vice president of laboratory operations, at right, leads Sen. Chris Murphy and other electeed officials on a tour Sema4 s laboratory at 62 Southfield Ave., in Stamford, Conn., on Sept. 18, 2020.Matthew Brown / Hearst Connecticut MediaShow MoreShow Less
2of6
Elected officials tour Sema4 s laboratory at 62 Southfield Ave., in Stamford, Conn., on Sept. 18, 2020.Matthew Brown / Hearst Connecticut MediaShow MoreShow Less
3of6
4of6
Sema4 opened in late 2020 its laboratory at 62 Southfield Ave., in Stamford, Conn.Matthew Brown / Hearst Connecticut MediaShow MoreShow Less
5of6
Sema4 opened in late 2020 its laboratory at 62 Southfield Ave., in Stamford, Conn.Matthew Brown / Hearst Connecticut MediaShow MoreShow Less